Dexrazoxane hydrochloride is a cardioprotective agent. It was discovered by Kurt
Hellmann in 1972. Dexrazoxane is a sterile, pyrogen-free lyophilizate intended ...
Dexrazoxane Injection: learn about side effects, dosage, special precautions, and
more on MedlinePlus.
Jul 2, 2013 ... On September 6, 2007, the FDA approved dexrazoxane hydrochloride for
injection (Totect™ made by TopoTarget USA, Inc.), equivalent to 500 ...
FDA Statement on Dexrazoxane. [07-20-2011]. The United States Food and Drug
Administration (FDA) is informing the public that on June 23, 2011, the ...
Int J Clin Pract. 2013 Mar;67(3):244-9. doi: 10.1111/ijcp.12103. Dexrazoxane
efficacy for anthracycline extravasation: use in UK clinical practice.
Jun 13, 2005 ... Dexrazoxane, the (+)-enantiomorph of razoxane, provides cardioprotection
against anthracycline toxicity. It appears to inhibit formation of a ...
Medscape - Indication-specific dosing for Totect, Zinecard (dexrazoxane),
frequency-based adverse effects, comprehensive interactions, contraindications,
May 14, 2013 ... Totect® (dexrazoxane for injection) is a sterile, pyrogen-free lyophilizate intended
for intravenous (IV) administration. Totect® is packaged as ...
Jul 16, 2012 ... ZINECARD® (dexrazoxane for injection) is a sterile, pyrogen-free lyophilizate
intended for intravenous administration. It is a cardioprotective ...
Pictures of Zinecard (Dexrazoxane), drug imprint information, side effects for the